Background Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic
comorbidities such as arterial hypertension and increased risk of cardiovascular disease …

CIRCULATING INTERLEUKIN-32 LEVELS ARE ASSOCIATED WITH ARTERIAL HYPERTENSION
IN INDIVIDUALS AT RISK OF NAFLD AKNOWLEDGEMENTS INTR Page 1 NAFLD2022 Scan …

Fatty liver disease is most frequently related to metabolic dysfunction (MAFLD) and
associated comorbidities, heightening the risk of cardiovascular disease, and is associated …

Background Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder characterised
by enhanced hepatic fat deposition and inflammation. Efforts to manage NAFLD are limited …

Objective Efforts to manage non-alcoholic fatty liver disease (NAFLD) are limited by the
incomplete understanding of the pathogenic mechanisms and the absence of accurate non …

Background Insulin resistance, liver injury and dyslipidemia are reported in non-alcoholic fat
liver disease (NAFLD) patients. Interleukin (IL)-38 may take part in the pathophysiology of …

Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder due to increased
accumulation of fat in the liver and in many cases to enhanced inflammation. Although the …

Methods: We used in vitro cultured hepatocytes and 3D spheroids derived from immortalized
hepatocytes and hepatic stellate cells, to understand the mechanisms through which IL32 …

Abstract Aim: Metabolic syndrome (MetS) is characterized by abdominal obesity,
dyslipidemia, low-grade inflammation, insulin resistance, and hypertension that can lead to …

Background & Aims Nonalcoholic fatty liver disease (NAFLD) is a major health problem with
complex pathogenesis. Although sex differences in NAFLD pathogenesis have been …